Uterine fibroids are a common disease that is found in almost 80—90% of women under the age of 50, observed according to various sources in 20—70% of women of reproductive age, and occurs in 0.5—6% of cases during pregnancy. In some cases, uterine fibroids do not prevent the onset of pregnancy and fetal development, however, they can increase the frequency of complications of pregnancy and childbirth, in addition, they can cause infertility. The effect of fibroids on the onset of pregnancy is determined by the localization, size and number of nodes. The modern view of the treatment of uterine fibroids includes wait-and-see tactics, medical and surgical treatment, as well as interventional radiological manipulations. Since currently the age of women planning pregnancy is generally increasing, there is a growing need for minimally invasive and sparing methods of surgical treatment of uterine fibroids. The main direction of modern organ-preserving surgical methods for the treatment of fibroids is tumor enucleation with subsequent closure of the incision of the uterus. Currently, a fairly large number of studies are being conducted aimed at determining the presence or absence of advantages of laparoscopic, hysteroscopic and laparotomic myomectomy. For women who want to preserve their uterus and who have not had a response to medication, relapses after myomectomy, embolization of the uterine arteries may be recommended. Each method has its advantages, but also possible complications. What kind of treatment can lead to the optimal result, ensure the highest quality of life, the least number of complications, reduction of symptoms and the least likelihood of intervention, has not been established to date and may depend on many factors and careful selection of patients.